RxDoctor Payments Data

Jonathan Nix, PA

Surgical · Athens, GANPI 1811087299

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.9% of the total across 317 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 19.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,362, 3.3 times the $707 reported in 2021. Among surgical clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,525in general payments, 2019–2025

Across 317 payments — averaging $23.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Sanofi$1K
  • Regeneron Healthcare Solutions, Inc.$634
  • Johnson & Johnson$536
  • E.r. Squibb & Sons, L.L.C.$533
  • Novartis$452
  • plus $3K from 21 others

What the payments were for

  • Food & beverage$7,518100%
  • Education$70%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,525 in reported general payments places this provider in the 90th percentile of 372 surgical providers in Georgia.

See all surgical providers in Georgia

Medicare billing

Part B allowed, 2024
$293,312
Medicare patients
960
Services billed
8,148

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Skyrizi PenRisankizumab-Rzaa23$473,739
Cosentyx Sensoready (2 Pens)Secukinumab24$177,040
Dupixent PenDupilumab24$88,168
Doxycycline Hyclate87$6,879
Ivermectin23$6,437
Ketoconazole247$4,764
Metronidazole80$4,365
Clobetasol Propionate126$3,960
Clindamycin Phosphate84$3,514
Triamcinolone Acetonide200$2,460
Mupirocin192$1,093
Desonide11$853
Fluorouracil11$812
ValacyclovirValacyclovir Hcl27$449
Cephalexin52$224

Paid to pharmacies, not to this prescriber.

Other surgical in Athens

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →